Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Andrew Pavelyev, n/a

Merck&Co.,Inc.

Disclosure(s): HCL America, Inc.: emplo

Poster(s):

(P-2) Public Health and Economic Impact of Implementing Gender-Neutral Vaccination with the 4-Valent Human Papillomavirus Vaccine in Costa Rica

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT
(P-3) Assessing the Public Health Impact of Transitioning from a 4-valent to a 9-valent HPV Vaccination Program in Panama

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT